Monograph Details

Infections & Infestations > Bacterial infections
BIAXIN
Manufacturer
Abbott Laboratories
Legal Classification
Rx
Pharmacological Class
Macrolide.
Generic Name
Clarithromycin 250mg, 500mg; tabs.
Also
BIAXIN ORAL SUSPENSION
BIAXIN XL
Indications
Mild to moderate susceptible pharyngitis/tonsillitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, acute maxillary sinusitis, acute otitis media, uncomplicated skin and skin structure infections. Disseminated M. intracellulare. Treatment (with other antimycobacterials) and prophylaxis of disseminated Mycobacterium avium complex (MAC).
Children
<6 months: not recommended. Otitis media, pharyngitis/tonsillitis, pneumonia, sinusitis, skin and skin structures: 7.5mg/kg every 12 hours for 10 days. MAC (see literature): 7.5mg/kg every 12 hours; max 500mg twice daily, continue indefinitely if improvement occurs. CrCl <30mL/min: ½ dose or double dosing interval.
Adults
Pharyngitis/tonsillitis: 250mg every 12 hours for 10 days. Bronchitis: 250mg–500mg every 12 hours for 7–14 days. CAP, skin and skin structures: 250mg every 12 hours for 7–14 days. Sinusitis: 500mg every 12 hours for 14 days. MAC: 500mg every 12 hours continue indefinitely if improvement occurs. CrCl <30mL/min: ½ dose or double dosing interval.
Contraindications
Concomitant cisapride, pimozide.
Precautions
Severe renal impairment. Pregnancy (Cat.C): usually not recommended. Nursing mothers.
Interactions
See Contraindications. May potentiate theophylline, carbamazepine, omeprazole, phenytoin, digoxin, warfarin, ergot alkaloids, triazolam, cyclosporine, hexobarbital, tacrolimus, alfentanil, disopyramide, bromocriptine, valproate, rifabutin, statins; monitor these and others metabolized by CYP450. May affect zidovudine levels. With ritonavir in renal impairment: reduce clarithromycin dose (see literature).
Adverse Reactions
GI upset, abnormal taste, headache, rash, increased BUN.
How Supplied
XL tabs, tabs—60
Biaxin XL-Pac (14 x 500mg XL tabs)—4
Susp—50mL, 100mL
Additional Resources
Related Prescribing Note